DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk

被引:38
作者
Bernard-Gallon, Dominique [1 ,2 ]
Bosviel, Remy [1 ,2 ]
Delort, Laetitia [1 ,2 ]
Fontana, Luc [3 ,4 ]
Chamoux, Alain [3 ,4 ]
Rabiau, Nadege [1 ,2 ]
Kwiatkowski, Fabrice [1 ,2 ]
Chalabi, Nassera [1 ,2 ]
Satih, Samir [1 ,2 ]
Bignon, Yves-Jean [1 ,2 ,3 ]
机构
[1] Ctr Jean Perrin, Dept Oncogenet, EA 2416, CBRV, F-63001 Clermont Ferrand 01, France
[2] CRNH, F-63009 Clermont Ferrand 01, France
[3] Univ Clermont 1, UFR Med, Inst Med Travail, F-63001 Clermont Ferrand, France
[4] CHU Clermont Ferrand, Serv Sante Travail Environm, F-63001 Clermont Ferrand, France
关键词
D O I
10.1186/1476-4598-7-36
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Breast and ovarian cancers increased in the last decades. Except rare cases with a genetic predisposition and high penetrance, these pathologies are viewed as a polygenic disease. In this concept, association studies look for genetic variations such as polymorphisms in low penetrance genes, i.e. genes in interaction with environmental factors. DNA repair systems that protect the genome from deleterious endogenous and exogenous damages have been shown to have significantly reduced. In particular, enzymes of the nucleotide excision repair pathway are suspected to be implicated in cancer. In this study, 2 functional polymorphisms in a DNA repair gene ERCC2 were analyzed. The population included 911 breast cancer cases, 51 ovarian cancer cases and 1000 controls. The genotyping of 2 SNP (Single Nucleotide Polymorphism) was carried out on the population with the MGB (Minor Groove Binder) probe technique which consists of the use of the allelic discrimination with the Taqman(R) method. This study enabled us to show an increase in risk of breast cancer with no oral contraceptive users and with women exhibiting a waist-to-hip ratio (WHR) > 0.85 for Asn homozygous for ERCC2 3/2.
引用
收藏
页数:7
相关论文
共 37 条
[1]   Anthropometric variables, physical activity, and incidence of ovarian cancer - The Iowa Women's Health Study [J].
Anderson, JP ;
Ross, JA ;
Folsom, AR .
CANCER, 2004, 100 (07) :1515-1521
[2]   Risk of ovarian cancer associated with BMI varies by menopausal status [J].
Beehler, Gregory P. ;
Sekhon, Manveen ;
Baker, Julie A. ;
Teter, Barbara E. ;
McCann, Susan E. ;
Rodabaugh, Kerry J. ;
Moysich, Kirsten B. .
JOURNAL OF NUTRITION, 2006, 136 (11) :2881-2886
[3]  
Bernard-Gallon DJ, 2001, INT J ONCOL, V18, P271
[4]   Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].
Calle, EE ;
Rodriguez, C ;
Walker-Thurmond, K ;
Thun, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638
[5]   Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH [J].
Coin, F ;
Marinoni, JC ;
Rodolfo, C ;
Fribourg, S ;
Pedrini, AM ;
Egly, JM .
NATURE GENETICS, 1998, 20 (02) :184-188
[6]   Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer [J].
Costa, Sandra ;
Pinto, Daniela ;
Pereira, Deolinda ;
Vasconcelos, Andre ;
Afonso-Lopes, Carlos ;
Osorio, Teresa ;
Lopes, Carlos ;
Medeiros, Rui .
CANCER LETTERS, 2007, 246 (1-2) :324-330
[7]   Body size indices at different ages and epithelial ovarian cancer risk [J].
Dal Maso, L ;
Franceschi, S ;
Negri, E ;
Conti, E ;
Montella, M ;
Vaccarella, S ;
Canzonieri, V ;
Parazzini, F ;
La Vecchia, C .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (13) :1769-1774
[8]  
Delort L, 2007, ANTICANCER RES, V27, P1087
[9]   Understanding breast cancer risk - where do we stand in 2005? [J].
Dumitrescu, RG ;
Cotarla, I .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2005, 9 (01) :208-221
[10]   Height, body mass index, and ovarian cancer: A follow-up of 1.1 million Norwegian women [J].
Engeland, A ;
Tretli, S ;
Bjorge, T .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (16) :1244-1248